About active pharmaceutical ingredient manufacturers
This sort of carryover mustn't result in the carryover of degradants or microbial contamination that may adversely alter the recognized API impurity profile.If devices is devoted to manufacturing a single intermediate or API, individual machines documents will not be essential if batches on the intermediate or API observe in traceable sequence.Proc